Division of Cyclotron and Radio-Pharmaceutical Sciences, Institute of Nuclear medicine and allied sciences, Brig S. K. Majumdar Road, Delhi-54, India.
Dalton Trans. 2013 Apr 14;42(14):4994-5003. doi: 10.1039/c2dt32391e.
Magnetic resonance (MR) imaging is widely used in clinical research to map the structural and functional organization of the brain. We have designed and synthesized a Gd-based specific MR contrast agent that binds to regions in the brain. The presented compound {4-[(4-benzothiazol-2-yl-phenylcarbamoyl)-methyl]-7,10-bis-carboxymethyl-1,4,7,10-tetraazacyclododec-1-yl} acetic acid (DO3A-BT) was synthesized by conjugating the chloroacetylated product of 4-benzothiazol-2-yl-phenylamine with a trisubstituted cyclen. The lanthanide complex (Ln-DO3A-BT) was evaluated in vitro for both MR (Gd-DO3A-BT) and optical (Eu-DO3A-BT) imaging applications. The complex Gd-DO3A-BT displays a relaxivity of r1 = 4.18 mM(-1) s(-1) at 4.7 T which is 1.2 times greater than Dotarem and significantly higher than the brain specific MR contrast agent Luxol Fast Blue (LFB). The protonation constant of the ligand (pKa1 = 9.91, pKa2 = 8.22, pKa3 = 5.01) and the stability constant of the complex formed between Gd(III), Eu(III) and Ca(II) and ligand DO3A-BT (log βGdL = 18.4, log βEuL = 18.3, log βZn2L = 7.1, log βCa2L = 6.3) were recorded by potentiometric titration. The constants reflect the high stability of the ligand with lanthanides compared with endogenous metal ions. The transmetalation stability of Gd-DO3A-BT toward Zn proved to be excellent with a rate constant of 3.07 × 10(-5) s(-1) which is in line with other tetraazatetraacetic acid (DOTA)-monoamide complexes. The hydration number (q) was found to be 0.92, and is calculated from the difference in the luminescence lifetime of Eu-DO3A-BT in H2O and D2O solutions to determine the coordination state of this complex. The in vivo biodistribution of (99m)Tc-DO3A-BT in BALB/c mice showed a brain uptake of 1.2% ID g(-1) at 2 min post injection when injected with mannitol which disrupts the blood-brain-barrier (BBB) due to osmotic shock. In vitro binding on the brain homogenate revealed a high uptake by the neuronal/glial cells for in vivo applications.
磁共振(MR)成像广泛应用于临床研究,用于绘制大脑的结构和功能组织图。我们设计并合成了一种基于钆的特异性磁共振对比剂,该对比剂可与大脑中的区域结合。所提出的化合物{4-[(4-苯并噻唑-2-基-苯基氨基甲酰基)-甲基]-7,10-双羧甲基-1,4,7,10-四氮杂环十二烷-1-基}乙酸(DO3A-BT)是通过将 4-苯并噻唑-2-基-苯胺的氯乙酰化产物与三取代的环庚烷偶联而合成的。该镧系元素配合物(Ln-DO3A-BT)在体外进行了磁共振(Gd-DO3A-BT)和光学(Eu-DO3A-BT)成像应用的评估。配合物 Gd-DO3A-BT 在 4.7 T 时的弛豫率 r1 = 4.18 mM-1 s-1,是 Dotarem 的 1.2 倍,明显高于脑特异性磁共振对比剂 Luxol Fast Blue(LFB)。配体的质子化常数(pKa1 = 9.91、pKa2 = 8.22、pKa3 = 5.01)和 Gd(III)、Eu(III)和 Ca(II)与配体 DO3A-BT 形成的配合物的稳定常数(log βGdL = 18.4、log βEuL = 18.3、log βZn2L = 7.1、log βCa2L = 6.3)通过电位滴定法记录。这些常数反映了配体与镧系元素相比与内源性金属离子的高稳定性。Gd-DO3A-BT 向 Zn 的转金属稳定性非常出色,其速率常数为 3.07×10-5 s-1,与其他四氮杂十二烷二酸(DOTA)-单酰胺配合物一致。水合数(q)为 0.92,是通过在 H2O 和 D2O 溶液中测定 Eu-DO3A-BT 的荧光寿命差异来确定该配合物的配位状态。(99m)Tc-DO3A-BT 在 BALB/c 小鼠体内的生物分布显示,在注射甘露醇后 2 分钟时脑摄取率为 1.2% ID g-1,由于渗透压休克破坏了血脑屏障(BBB)。在体外结合脑匀浆上,对于体内应用,神经元/神经胶质细胞具有高摄取率。